Matches in Nanopublications for { ?s ?p "[JAK2 exon 12 mutation screening is indicated only in the presence of JAK2V617F-negative erythrocytosis that is associated with a subnormal serum erythropoietin level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP154907.RAzmM9CL-i5-aWZMIC_56cmU2bh4Pfd2R2_SbmEhqQ1g4130_assertion description "[JAK2 exon 12 mutation screening is indicated only in the presence of JAK2V617F-negative erythrocytosis that is associated with a subnormal serum erythropoietin level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP154907.RAzmM9CL-i5-aWZMIC_56cmU2bh4Pfd2R2_SbmEhqQ1g4130_provenance.
- NP906575.RAbxMWNSLol1hdMTM_Nl_45fxi3WcI1hzcU3zF8UWDzw8130_assertion description "[JAK2 exon 12 mutation screening is indicated only in the presence of JAK2V617F-negative erythrocytosis that is associated with a subnormal serum erythropoietin level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906575.RAbxMWNSLol1hdMTM_Nl_45fxi3WcI1hzcU3zF8UWDzw8130_provenance.
- NP906576.RAVBFT4bh7JS0axWUyK8sy5PmYdZ28dPJOVNF3Ov7a_AU130_assertion description "[JAK2 exon 12 mutation screening is indicated only in the presence of JAK2V617F-negative erythrocytosis that is associated with a subnormal serum erythropoietin level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906576.RAVBFT4bh7JS0axWUyK8sy5PmYdZ28dPJOVNF3Ov7a_AU130_provenance.
- NP519727.RAsjSp5SyPvk0nfASO9-_F0X-es9Os3sIwPZXOseA8zlo130_assertion description "[JAK2 exon 12 mutation screening is indicated only in the presence of JAK2V617F-negative erythrocytosis that is associated with a subnormal serum erythropoietin level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519727.RAsjSp5SyPvk0nfASO9-_F0X-es9Os3sIwPZXOseA8zlo130_provenance.
- NP378316.RAh5dexWneidMkcjV5LOfWO0WWlx3xtb07qa-C1-7rcGY130_assertion description "[JAK2 exon 12 mutation screening is indicated only in the presence of JAK2V617F-negative erythrocytosis that is associated with a subnormal serum erythropoietin level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378316.RAh5dexWneidMkcjV5LOfWO0WWlx3xtb07qa-C1-7rcGY130_provenance.
- NP906577.RAHp3NNi9lHQsSCAfQGCU6OpXqiG350HS591uOBNq7hZI130_assertion description "[JAK2 exon 12 mutation screening is indicated only in the presence of JAK2V617F-negative erythrocytosis that is associated with a subnormal serum erythropoietin level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906577.RAHp3NNi9lHQsSCAfQGCU6OpXqiG350HS591uOBNq7hZI130_provenance.
- NP906578.RANCB_DRgrazONlcvvmNqdCWaIGlCXnm_c_IetjZzQdA8130_assertion description "[JAK2 exon 12 mutation screening is indicated only in the presence of JAK2V617F-negative erythrocytosis that is associated with a subnormal serum erythropoietin level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906578.RANCB_DRgrazONlcvvmNqdCWaIGlCXnm_c_IetjZzQdA8130_provenance.